Induction chemotherapy followed by concomitant chemoradiation-induced regression of advanced cervical lymphadenopathy in head and neck cancer as a predictor of outcome

Otolaryngology - Head and Neck Surgery

Volumn 126, Issue 6, 2002, Pages 602-606

  Ampil, Federico L ^a,b   Mills, Glenn M ^a,b   Caldito, Gloria ^a,c   Burton, Gary V ^a,b   Nathan, Cherie Ann O ^a,b   Aarstad, Robert F ^a,b   Lian, Timothy F ^a,b   Stucker, Fred J ^a,b   Hardin Jr , John C ^a,b  

^a Louisiana State University Health Sciences Center ^*

^b Louisiana State University School of Medicine Shreveport   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DENTAL CARIES; FEMALE; GAMMA RADIATION; HEAD AND NECK CANCER; HUMAN; LEUKOPENIA; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCOSA INFLAMMATION; NECK DISSECTION; PROGNOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR REGRESSION; ADJUVANT THERAPY; DRUG EFFECT; HEAD AND NECK TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PREDICTION AND FORECASTING; RADIATION DOSE; RADIATION EXPOSURE; REMISSION; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIATION DOSAGE; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036596308     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2002.125606     Document Type: Article

References (19)

1. Bataini JP, Bernier J, Jaulerry C, et al. Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolaryngeal cancers managed by definitive radiotherapy. Int J Radiat Oncol Biol Phys 1987;13:817-24.
2. Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg 1985;150:414-21.
3. Richard JM, Sancho-Garnier H, Micheau C, et al. Prognostic factors in cervical lymph node metastasis in upper respiratory and digestive tract carcinomas: study of 1,713 cases during a 15-year period. Laryngoscope 1987;97:97-101.
4. Armstrong J, Pfister D, Strong E, et al. The management of the clinically positive neck as a part of larynx preservation approach. Int J Radiat Oncol Biol Phys 1993;26:759-65.
5. Clayman GL, Johnson CJ, Morrison W, et al. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001;127:135-39.
6. Dagum P, Pinto HA, Newman JP, et al. Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Am J Surg 1998;176:448-52.
7. Sanguineti G, Corvo R, Benasso M, et al. Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer. Head Neck 1999;21:223-28.
8. Lavertu P, Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997;19:559-66.
9. Ampil FL, Mills GM, Stacker FJ, et al. Radical combined treatment of locally extensive head and neck cancer in the elderly. Am J Otolaryngol 2001;22:65-9.
10. Ampil F, Datta R, Shockley W. Adjuvant postoperative external beam radiotherapy in head and neck cancer. J Oral Maxillofac Surg 1988;46:569-573.
11. Johnson CR, Silverman LN, Clay LB, et al. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is postradiotherapy neck dissection necessary? Radiat Oncol Invest 1998;6:52-7.
12. Wittes RE. Introduction, single agent versus combination chemotherapy. In: Chretien PB, Johns ME, Shedd DP, et al, editors. Head and neck cancer. Philadelphia, PA: BC Decker; 1985. pp. 424-5.
13. Kies MS, Levitan N, Hong WK. Chemotherapy of head and neck cancer. Otolaryngol Clin North Am 1985;18:533-41.
14. Forastiere AA. Randomized trials of induction chemotherapy. Hematol/Oncol Clin North Am 1991;5:725-36.
15. Koch WM, Lee DJ, Eisele DW, et al. Chemoradiotherapy for organ preservation in oral and pharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1995;121:974-80.
16. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy. Arch Otolaryngol Head Neck Surg 2000;126: 950-56.
17. Weisman RA, Christen RD, Jones VE, et al. Observations on control of N2 and N3 neck disease in squamous cell carcinoma of the head and neck by intra-arterial chemoradiation. Laryngoscope 1998;108:800-05.
18. Wolf GT, Fisher SG. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992;102:934-39.
19. Kies MS, Haraf DJ, Athanasiadis I, et al. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. J Clin Oncol 1998;16:2715-21.